- Home
- TMDX vs FINV Comparison
TMDX vs FINV Comparison
Compare TMDX & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- FINV
- Stock Information
- Founded
- TMDX 1998
- FINV 2007
- Country
- TMDX United States
- FINV China
- Employees
- TMDX N/A
- FINV N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FINV Finance: Consumer Services
- Sector
- TMDX Health Care
- FINV Finance
- Exchange
- TMDX Nasdaq
- FINV Nasdaq
- Market Cap
- TMDX 2.3B
- FINV 2.2B
- IPO Year
- TMDX 2019
- FINV N/A
- Fundamental
- Price
- TMDX $127.12
- FINV $8.35
- Analyst Decision
- TMDX Buy
- FINV Strong Buy
- Analyst Count
- TMDX 10
- FINV 2
- Target Price
- TMDX $122.89
- FINV $11.55
- AVG Volume (30 Days)
- TMDX 1.2M
- FINV 870.0K
- Earning Date
- TMDX 05-08-2025
- FINV 05-20-2025
- Dividend Yield
- TMDX N/A
- FINV 3.31%
- EPS Growth
- TMDX N/A
- FINV 26.19
- EPS
- TMDX 1.41
- FINV 1.37
- Revenue
- TMDX $488,227,000.00
- FINV $1,846,779,164.00
- Revenue This Year
- TMDX $32.58
- FINV $14.79
- Revenue Next Year
- TMDX $21.65
- FINV $10.77
- P/E Ratio
- TMDX $90.23
- FINV $6.09
- Revenue Growth
- TMDX 64.43
- FINV 5.40
- 52 Week Low
- TMDX $55.00
- FINV $4.63
- 52 Week High
- TMDX $177.37
- FINV $11.08
- Technical
- Relative Strength Index (RSI)
- TMDX 76.52
- FINV 47.46
- Support Level
- TMDX $118.79
- FINV $8.29
- Resistance Level
- TMDX $130.48
- FINV $8.78
- Average True Range (ATR)
- TMDX 4.49
- FINV 0.35
- MACD
- TMDX -0.15
- FINV -0.01
- Stochastic Oscillator
- TMDX 83.53
- FINV 7.90
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About FINV FinVolution Group
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.